Tobinco Pharmaceuticals Limited has assured its customers that a compensation arrangement has been instituted for the recall of an anti- malaria drug called Gsunate Plus Suppository; combination of Artesunate 25mg and Amodiaquine 75mg, from the market. They are also assisting the Food and Drugs Authority (FDA) to rid the the system of the medicine. Tobinco Pharmaceuticals has directed all hospitals, clinics, pharmacies, licensed chemical sellers and other health facilities having stocks of Gsunate Plus Suppository to immediately handover stocks to its Regional offices or the nearest FDA office countrywide for safe disposal.
Help employers find you! Check out all the jobs and post your resume.
